Single-speciality hospitals and clinics surge, driven by patient demand and investor interest

There is a quiet but significant churn in India’s healthcare sector.

The once-dominant multi-speciality hospital model—designed to treat everything from cardiac emergencies to cataracts under one roof—is steadily ceding space to single-speciality hospitals and clinics built around focused care and repeatable workflows.

According to a report by venture capital firm Besser Venture Partners, the shift is driven by several factors: a sharp rise in health insurance coverage, an ageing population, growing private capital, and patient preference for specialised expertise.

Together, they are reshaping how healthcare is delivered and where the sector’s next phase of growth is likely to come from.

India’s healthcare provider market is expected to grow from about $54 billion in 2025 to about $95 billion by 2030, expanding at more than 10% annually, according to the report. Single-speciality providers—focused on areas such as eye care, fertility, dialysis, oncology day care, and post-acute rehabilitation—are projected to grow more than twice as fast, at around 22% a year. The organised single-speciality segment alone is expected to nearly triple in size over the same period. 

However, multi-speciality hospitals will remain indispensable for complex, high-acuity procedures such as organ transplants, neurosurgery, and advanced cardiac care, areas that require large teams, cross-disciplinary expertise, and heavy capital investment.

But standardised, protocol-driven treatments are increasingly migrating to focused providers that can deliver them more efficiently and consistently.

Meanwhile, health insurance penetration in India has doubled over the past decade, reaching about 40% of the population, supported by large public schemes such as Ayushman Bharat and the expansion of private coverage.

As reimbursement improves, healthcare providers focused on predictable procedures and clear pricing have gained an advantage.

Single-speciality providers benefit from structural cost advantages. Purpose-built facilities allow tighter control over capital expenditure, standardised layouts, centralised procurement, and repeatable workflows.

The workflow involves both clinical and administrative tasks designed for a specific medical focus.

Many focused care providers achieve payback from new centres within 12 to 18 months and operate with EBITDA margins exceeding 20%, the report notes. These metrics have drawn sustained interest from private equity and growth investors.

Operational design has become a differentiator. Focused chains can scale through hub-and-spoke models, which place smaller centres closer to patients while centralising expertise, procurement, and quality controls. This approach is particularly relevant in Tier II and III cities, where access to consistent, high-quality care remains uneven and fragmented.

However, despite the rapid growth of focused healthcare chains, most specialities remain far from consolidated.

Even by the end of the decade, sectors such as dental care, oncology, and eye care are unlikely to be more than 60% organised. This gives a lot of room for new entrants to build brands, set clinical standards, and pursue roll-up strategies in fragmented markets.

The public markets appear to be validating the focused model. Listed single-specialty providers have traded at valuations comparable to, and in some cases exceeding, those of larger multi-speciality hospital chains.

This reflects investor emphasis on capital efficiency, predictable growth, and quality of earnings rather than sheer scale.

Having said that, the path is not without risks. Single-speciality businesses are vulnerable to execution failures, dependence on reputed physicians, regulatory complexities, and brand dilution as they scale.

Areas that rely heavily on individual doctor reputation or require multidisciplinary coordination tend to expand more slowly, and often through acquisitions rather than organic rollouts.

Going forward, even as large hospitals concentrate on complex, premium procedures, focused providers will emerge alongside to handle high-volume, standardised care, often at lower costs and closer to where patients live.